- Home
- NTCT vs IDYA Comparison
NTCT vs IDYA Comparison
Compare NTCT & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTCT
- IDYA
- Stock Information
- Founded
- NTCT 1984
- IDYA 2015
- Country
- NTCT United States
- IDYA United States
- Employees
- NTCT N/A
- IDYA N/A
- Industry
- NTCT EDP Services
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- NTCT Technology
- IDYA Health Care
- Exchange
- NTCT Nasdaq
- IDYA Nasdaq
- Market Cap
- NTCT 1.7B
- IDYA 2.0B
- IPO Year
- NTCT 1999
- IDYA 2019
- Fundamental
- Price
- NTCT $21.30
- IDYA $14.77
- Analyst Decision
- NTCT Hold
- IDYA Strong Buy
- Analyst Count
- NTCT 1
- IDYA 13
- Target Price
- NTCT $25.00
- IDYA $53.58
- AVG Volume (30 Days)
- NTCT 472.0K
- IDYA 973.2K
- Earning Date
- NTCT 05-08-2025
- IDYA 05-06-2025
- Dividend Yield
- NTCT N/A
- IDYA N/A
- EPS Growth
- NTCT N/A
- IDYA N/A
- EPS
- NTCT N/A
- IDYA N/A
- Revenue
- NTCT $821,135,000.00
- IDYA $7,000,000.00
- Revenue This Year
- NTCT $0.09
- IDYA $89.14
- Revenue Next Year
- NTCT $2.06
- IDYA $291.34
- P/E Ratio
- NTCT N/A
- IDYA N/A
- Revenue Growth
- NTCT N/A
- IDYA N/A
- 52 Week Low
- NTCT $17.10
- IDYA $14.40
- 52 Week High
- NTCT $27.89
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- NTCT 43.51
- IDYA 22.34
- Support Level
- NTCT $20.81
- IDYA $17.05
- Resistance Level
- NTCT $22.07
- IDYA $18.90
- Average True Range (ATR)
- NTCT 0.46
- IDYA 0.95
- MACD
- NTCT 0.07
- IDYA -0.17
- Stochastic Oscillator
- NTCT 55.23
- IDYA 7.13
About NTCT NetScout Systems Inc.
NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.